The early phase of the Douglas study saw 234 patients with treatment-resistant depression being given extended-release oral doses of ketamine [photo: Nik Shuliahin on Unsplash]
Douglas Pharmaceuticals is heralding early results of its trial on using ketamine to treat depression as possibly the most significant step in the fie
Chemist Warehouse is sponsoring the Young Pharmacist of the Year Award in the 2025 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora. The Chemist Warehouse leadership team explains what it means to be a Stellar Supporter